BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 22369497)

  • 1. Female genital tract shedding of CXCR4-tropic HIV Type 1 is associated with a majority population of CXCR4-tropic HIV Type 1 in blood and declining CD4(+) cell counts.
    Haaland RE; Sullivan ST; Evans-Strickfaden T; Lennox JL; Hart CE
    AIDS Res Hum Retroviruses; 2012 Nov; 28(11):1524-32. PubMed ID: 22369497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences in molecular evolution between switch (R5 to R5X4/X4-tropic) and non-switch (R5-tropic only) HIV-1 populations during infection.
    Mild M; Kvist A; Esbjörnsson J; Karlsson I; Fenyö EM; Medstrand P
    Infect Genet Evol; 2010 Apr; 10(3):356-64. PubMed ID: 19446658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV-1 dual/mixed tropic isolates show different genetic and phenotypic characteristics and response to maraviroc in vitro.
    Svicher V; Balestra E; Cento V; Sarmati L; Dori L; Vandenbroucke I; D'Arrigo R; Buonomini AR; Van Marck H; Surdo M; Saccomandi P; Mostmans W; Aerssens J; Aquaro S; Stuyver LJ; Andreoni M; Ceccherini-Silberstein F; Perno CF
    Antiviral Res; 2011 Apr; 90(1):42-53. PubMed ID: 21349294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Existence of Replication-Competent Minor Variants with Different Coreceptor Usage in Plasma from HIV-1-Infected Individuals.
    Maeda Y; Takemura T; Chikata T; Kuwata T; Terasawa H; Fujimoto R; Kuse N; Akahoshi T; Murakoshi H; Tran GV; Zhang Y; Pham CH; Pham AHQ; Monde K; Sawa T; Matsushita S; Nguyen TV; Nguyen KV; Hasebe F; Yamashiro T; Takiguchi M
    J Virol; 2020 Jun; 94(12):. PubMed ID: 32295903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accelerated in vivo proliferation of memory phenotype CD4+ T-cells in human HIV-1 infection irrespective of viral chemokine co-receptor tropism.
    Zhang Y; de Lara C; Worth A; Hegedus A; Laamanen K; Beverley P; Macallan D
    PLoS Pathog; 2013; 9(4):e1003310. PubMed ID: 23637601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic Immune Recovery and Reduction of CXCR4-Tropic HIV-1.
    Bader J; Däumer M; Schöni-Affolter F; Böni J; Gorgievski-Hrisoho M; Martinetti G; Thielen A; Klimkait T;
    Clin Infect Dis; 2017 Feb; 64(3):295-300. PubMed ID: 27838645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of HIV tropism on decreases in CD4 cell count, clinical progression, and subsequent response to a first antiretroviral therapy regimen.
    Waters L; Mandalia S; Randell P; Wildfire A; Gazzard B; Moyle G
    Clin Infect Dis; 2008 May; 46(10):1617-23. PubMed ID: 18419499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Higher prevalence of predicted X4-tropic strains in perinatally infected older children with HIV-1 subtype C in India.
    Neogi U; Sahoo PN; Arumugam K; Sonnerborg A; De Costa A; Shet A
    J Acquir Immune Defic Syndr; 2012 Apr; 59(4):347-53. PubMed ID: 22107818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complex determinants in human immunodeficiency virus type 1 envelope gp120 mediate CXCR4-dependent infection of macrophages.
    Ghaffari G; Tuttle DL; Briggs D; Burkhardt BR; Bhatt D; Andiman WA; Sleasman JW; Goodenow MM
    J Virol; 2005 Nov; 79(21):13250-61. PubMed ID: 16227248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Purifying selection of CCR5-tropic human immunodeficiency virus type 1 variants in AIDS subjects that have developed syncytium-inducing, CXCR4-tropic viruses.
    Fernàndez G; Llano A; Esgleas M; Clotet B; Esté JA; Martínez MA
    J Gen Virol; 2006 May; 87(Pt 5):1285-1294. PubMed ID: 16603531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hybrid approach for predicting coreceptor used by HIV-1 from its V3 loop amino acid sequence.
    Kumar R; Raghava GP
    PLoS One; 2013; 8(4):e61437. PubMed ID: 23596523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficiency of CCR5 coreceptor utilization by the HIV quasispecies increases over time, but is not associated with disease progression.
    Redd AD; Laeyendecker O; Kong X; Kiwanuka N; Lutalo T; Huang W; Gray RH; Wawer MJ; Serwadda D; Eshleman SH; Quinn TC;
    AIDS Res Hum Retroviruses; 2012 Mar; 28(3):289-94. PubMed ID: 21663455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV-1 chemokine coreceptor utilization in paired cerebrospinal fluid and plasma samples: a survey of subjects with viremia.
    Spudich SS; Huang W; Nilsson AC; Petropoulos CJ; Liegler TJ; Whitcomb JM; Price RW
    J Infect Dis; 2005 Mar; 191(6):890-8. PubMed ID: 15717264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Next generation sequencing reveals a high frequency of CXCR4 utilizing viruses in HIV-1 chronically infected drug experienced individuals in South Africa.
    Matume ND; Tebit DM; Gray LR; Hammarskjold ML; Rekosh D; Bessong PO
    J Clin Virol; 2018 Jun; 103():81-87. PubMed ID: 29661652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential effects of R5 and X4 human immunodeficiency virus type 1 infection on CD4+ cell proliferation and activation.
    Locher CP; Witt SA; Kassel R; Dowell NL; Fujimura S; Levy JA
    J Gen Virol; 2005 Apr; 86(Pt 4):1171-1179. PubMed ID: 15784911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phenotypic and genotypic comparisons of CCR5- and CXCR4-tropic human immunodeficiency virus type 1 biological clones isolated from subtype C-infected individuals.
    Pollakis G; Abebe A; Kliphuis A; Chalaby MI; Bakker M; Mengistu Y; Brouwer M; Goudsmit J; Schuitemaker H; Paxton WA
    J Virol; 2004 Mar; 78(6):2841-52. PubMed ID: 14990703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deep-Sequencing Analysis of the Dynamics of HIV-1 Quasiespecies in Naive Patients during a Short Exposure to Maraviroc.
    Cascajero A; Rastrojo A; Díez-Fuertes F; Hernández-Novoa B; Aguado B; Moreno S; Alcami J; Pérez-Olmeda M
    J Virol; 2018 Jun; 92(11):. PubMed ID: 29563289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Presence of HIV-1 R5 viruses in cerebrospinal fluid even in patients harboring R5X4/X4 viruses in plasma.
    Soulié C; Tubiana R; Simon A; Lambert-Niclot S; Malet I; Canestri A; Brunet C; Murphy R; Katlama C; Calvez V; Marcelin AG
    J Acquir Immune Defic Syndr; 2009 May; 51(1):60-4. PubMed ID: 19390328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Co-receptor switch during HAART is independent of virological success.
    Saracino A; Monno L; Cibelli DC; Punzi G; Brindicci G; Ladisa N; Tartaglia A; Lagioia A; Angarano G
    J Med Virol; 2009 Dec; 81(12):2036-44. PubMed ID: 19856465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinct molecular pathways to X4 tropism for a V3-truncated human immunodeficiency virus type 1 lead to differential coreceptor interactions and sensitivity to a CXCR4 antagonist.
    Del Prete GQ; Leslie GJ; Haggarty B; Jordan AP; Romano J; Hoxie JA
    J Virol; 2010 Sep; 84(17):8777-89. PubMed ID: 20573813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.